How to read this definition
Inclusion criteria describe evidence that can establish this activity. Exclusion criteria identify circumstances that do not establish it on that basis alone. The evaluation remains connected to its taxonomy version and supporting evidence.
Can establish this activity
Included when supported
Evidence may support involvement when it matches one or more of these inclusion criteria.
7 criteria
- 01Criterion
Include licensed or otherwise authorized cultivators producing cannabis for medical supply.
- 02Criterion
Include manufacturers and processors of medical cannabis flower, extracts, oils, capsules, sprays, edibles, devices, or other regulated medical products.
- 03Criterion
Include pharmaceutical or biotechnology companies actively developing cannabis-derived or cannabinoid medicines for human medical use.
- 04Criterion
Include licensed medical-cannabis distributors, pharmacies, dispensaries, and direct patient-supply businesses.
- 05Criterion
Include producers or commercial rights holders of approved or prescription cannabinoid medicines.
- 06Criterion
Include entities operating under a formal medical-cannabis, pharmaceutical, clinical-trial, compassionate-access, or patient-supply framework.
- 07Criterion
Include contract manufacturers, testing laboratories with product-release responsibility, and processors directly handling medical-cannabis products under a commercial agreement.
Does not establish this activity on its own
Excluded on this basis alone
These circumstances do not establish this activity unless separate evidence also meets an inclusion criterion.
6 criteria
- 01Criterion
Exclude activity limited to recreational or adult-use cannabis.
- 02Criterion
Exclude industrial hemp, hemp seed, fibre, food, cosmetics, or general-wellness CBD where no medical or pharmaceutical positioning is established.
- 03Criterion
Exclude pharmaceutical and biotechnology companies without a current cannabis-derived or cannabinoid product or programme.
- 04Criterion
Exclude real estate, finance, packaging, lighting, software, consulting, security, advertising, and other ancillary services without direct handling or commercial rights in the qualifying product.
- 05Criterion
Exclude academic, public-sector, or non-commercial research without a commercial medical-cannabis or cannabinoid product role.
- 06Criterion
Exclude consumer wellness retailers whose cannabis-derived products lack medical authorization, prescription, clinical, or therapeutic positioning.
Evidence and evaluation methodology
How sources, entity pathways, decisions, qualifiers, and review history are handled.
Map screens to a client policy
How to choose provider screens, document coverage, and decide what happens after an outcome.